Knott David M Jr Protagonist Therapeutics, Inc Transaction History
Knott David M Jr
- $160 Million
- Q1 2025
A detailed history of Knott David M Jr transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Knott David M Jr holds 76,000 shares of PTGX stock, worth $4.12 Million. This represents 2.3% of its overall portfolio holdings.
Number of Shares
76,000
Previous 52,368
45.13%
Holding current value
$4.12 Million
Previous $2.02 Million
81.84%
% of portfolio
2.3%
Previous 1.17%
Shares
2 transactions
Others Institutions Holding PTGX
# of Institutions
299Shares Held
61.3MCall Options Held
1.01MPut Options Held
555K-
Farallon Capital Management LLC San Francisco, CA6.11MShares$331 Million1.7% of portfolio
-
Black Rock Inc. New York, NY5.76MShares$312 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.72MShares$310 Million4.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.28MShares$232 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3MShares$163 Million5.07% of portfolio
About Protagonist Therapeutics, Inc
- Ticker PTGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,084,100
- Market Cap $2.66B
- Description
- Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...